Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients ...

Experts have discovered that prolonged periods of sitting or lying down could heighten the risk of dementia. A recent study ...

Guwahati: In a significant advancement for yak genomic science, the first-ever chromosome-level genome of the Indian yak (Bos ...

A single daily habit has been linked to an increased risk of dementia in older adults, regardless of their exercise habits, ...

Douglas A. Tremblay, MD, discusses the importance of quality-of-life data from treating patients with polycythemia vera with ...

Atara Biotherapeutics continues to salami slice its head count, this time laying off 30% of what remains of the biopharma's ...

Researchers now say such behavior could increase the risk of the disease that contributes to the deaths of more than 120,000 ...

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and ...

Increased sedentary behaviour, time spent sitting or lying down was associated with worse cognition and brain shrinkage in ...

Scientists have developed a cortical organoid model for UBA5-associated encephalopathy, revealing a new way to possibly address developmental defects.

Dosing complete in the first two cohorts of INLIGHT trial in obesity of WVE-007 (INHBE siRNA), designed to induce healthy weight loss by reducing fat without impacting muscle; clinical data on track ...

Dosing complete in the first two cohorts of INLIGHT trial in obesity of WVE-007 (INHBE siRNA), designed to induce healthy weight loss by reducing fat without impacting muscle; clinical data on track ...